Fischer Medical Ventures Limited (FISCHER) — Board Meeting | 14 August 2026(3 announcements)
Fischer Medical Ventures announced the resignation of two independent directors, Roberto Pagdanganan and Sanjay Jain, effective close of business on August 14, 2026, citing personal reasons and no material cause, as confirmed in their resignation letters.
Fischer Medical Ventures announced the conversion of 2,05,05,909 warrants into equity shares at Rs 23.40 each, generating Rs 35.99 crores from a 75% cash payment of Rs 17.55 per warrant. The allotment includes promoter and non-promoter holders, with total consideration received at Rs 35.99 crores.
The board approved unaudited Q1 FY2026 results showing a ₹350.41 crores net loss, reconstituted committees after two independent director resignations, and allotted 20.51 million shares at ₹23.40 per share following warrant conversions. The filing confirms no material impact from audit adjustments on annual results.
About Fischer Medical Ventures Limited (FISCHER)
Healthcare · Healthcare Equipment & Supplies · Listed on NSE
📡 Get AI alerts when FISCHER files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track FISCHER — Free💡 Ask AI about this filing
📊 More FISCHER filings
- 🟡 Board Meeting — 15 August 2026
- 🟡 Board Meeting — 13 August 2026 Fischer Medical Ventures Limited announced the board-approved allotment of 1,42,78,217 equity shares...
- Announcement — 13 August 2026 Fischer Medical Ventures disclosed that its Monitoring Agency Report for the quarter ended June 30, ...
- 🟡 Board Meeting — 12 August 2026 Fischer Medical Ventures Limited announced the board's approval on August 12, 2026, to convert 66,31...
- 🟡 Board Meeting — 11 August 2026 Fischer Medical Ventures Limited announced the board's approval on August 11, 2026, to convert 23 la...
🔥 Also filed on 14 August 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when FISCHER files new disclosures
Track FISCHER filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track FISCHER — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research